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The gene for spinocerebellar ataxia 7 (SCA7) includes a 
transcribed, translated CAG tract that is expanded in 
SCA7 patients. We have determined expansions in 73 
individuals from 17 SCA7 kindreds and compared them 
with repeat lengths of 180 unaffected individuals. 
Subjects with abnormal expansions comprise 59 
clinically affected individuals and 14 at-risk currently 
unaffected individuals predicted to carry the mutation by 
haplotype analysis. For expanded alleles, CAG repeat 
length correlates with disease progression and severity 
and correlates inversely with age of onset. Increased 
repeat lengths are seen in generational transmission of 
the disease allele, consistent with the pattern of clinical 
anticipation seen in these kindreds. Repeat lengths in 
expanded alleles show somatic mosaicism in leukocyte 
DNA, suggesting that these alleles are unstable within 
individuals as well as between generations. Although 
dynamic repeat expansions from paternal transmissions 
are greater than those from maternal transmissions, 
maternal transmission of disease is more common, 
suggesting germline or embryonic effects of the repeat 
expansion.
INTRODUCTION
The autosomal dominant spinocerebellar ataxias (SCAs) are a 
heterogeneous group of hereditary diseases manifested by 
degeneration of the cerebellum (primarily cortex) with associated 
variable pathology in other neural structures, including the
inferior olivary nucleus, basal ganglia, spinal cord, retina and 
peripheral nerves. Clinical manifestations of progressive ataxia, 
dysarthria and dysmetria may be accompanied by an associated 
constellation of associated deficits including ophthalmoplegia, 
visual loss, dementia, sensory deficits and pyramidal and/or 
extrapyramidal signs, depending on the underlying genetic 
defect. Previously defined on the basis of clinical (1) and 
pathological (2) critera, this complex group of diseases has been 
delineated by the discovery of distinct disease-causing genetic 
loci (3-8). More recently, successful cloning and determination 
of several disease-causing mutations have been accomplished for 
many of these diseases (9-13). We (14) have described families 
with SCA distinguished by associated pigmentary macular 
dystrophy and retinal degeneration leading to blindness, which 
we designated SCA7 (15). Previous nomenclature for SCA7 
includes autosomal dominant cerebellar ataxia (ADCA) type II
(1) and olivopontocerebellar ataxia (OPCA) type III (2). We (15) 
and others (16,17) previously have mapped the disease-causing 
gene to the short arm of chromosome 3 (3p12-13). Following this 
linkage information, SCA7 recently has been characterized (18).
The striking anticipation seen in this disease (14) mirrors that 
seen in other SCAs including SCA1, SCA2 and SCA3/Machado- 
Joseph disease (MJD), as well as other neurodegenerative 
diseases such as Huntington’s disease (HD), dentatorubralpalli- 
doluysian atrophy/Haw River/Smith’s disease (DRPLA) and 
spinal bulbar muscular atrophy/Kennedy’s disease (SBMA). The 
underlying mutation in these neuropathologies is a transcribed, 
translated CAG repeat coding for a polyglutamine tract that is 
expanded in affected individuals [for review, see (19,20)]. As 
predicted by clinical (14), cellular (21) and molecular (22) 
studies, this appears to be the case in SCA7 as well. We have
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investigated the length of the polyglutamine tract in affected 
individuals from several large previously described kindreds (15) 
as well as from other large and several smaller kindreds diagnosed 
as carrying the phenotype attributed to SCA7, and we have 
compared repeat length with a large sample of unrelated 
unaffected individuals.
RESULTS
Repeat length determination in affected and unaffected 
individuals
Repeat length distribution among three population groups studied 
is shown in Figure 1a. The distribution of unexpanded alleles is 
similar for CEPH, unaffected and affected SCA7 kindred 
individuals (Fig. 1b), with (CAG )10 by far the most common 
allele (71.5% of all unexpanded alleles). CAG repeat lengths 
ranged from six to 17 in 427 unexpanded chromosomes, with a 
mean of 10.5 ± 1.1 and median of 10 repeats. Unexpanded alleles 
showed no mutation, and genotype distribution in this group is 
consistent with Hardy-Weinberg equilibrium. Unrelated 
unaffected individuals taken from the CEPH panel had 34.3% 
observed repeat length heterozygosity (36/105 individuals); 
36.6% by the HET equation (210 chromosomes). Unaffected 
SCA7 kindred subjects incorporating both marry-ins and 
asymptomatic individuals not carrying the disease genotype 
showed greater heterozygosity (54.3% observed, 57.1% by HET, 
n = 144 chromosomes). This may be due to the fact that the CEPH 
reference panel has a preponderance of individuals of European 
origin, whereas many of the SCA7 kindreds are drawn from a 
broader geographic region (see Materials and Methods).
Seventy three expanded alleles (>17 repeats) from 59 patients 
and 14 asymptomatic at-risk individuals carrying the disease 
genotype ranged from 34 to 103 CAG repeats (Fig. 1c). The mean 
repeat length among these alleles was 49.4 ± 11.0 with a median 
of 47 repeats. Analysis of expanded repeats showed somatic 
variation in DNA derived from peripheral blood lymphocytes 
(Fig. 2), with expanded repeat lengths varying from ±1 to ±3 
repeats from the most prominent band per sample; such 
heterogeneity was not seen in unexpanded alleles. Although the 
possibility of PCR infidelity for larger expansions cannot be ruled 
out, the use of polymerase with proofreading/exonuclease 
activity makes this less likely.
Repeat length correlation with age of onset, disease 
severity and generation
As is seen in other trinucleotide repeat expansion diseases with 
anticipation, there is an inverse correlation between repeat length 
and age of onset. Age of onset in 59 clinically affected individuals 
ranged from 3.5 to 60 years. Mean age of onset was 29.9, with a 
standard deviation of 14.4 years. Correlation between SCA7 age 
of onset and CAG repeat length using quadratic regression 
analysis gave a Pearson coefficient of r = -0.80 (P<0.0001) 
(Fig. 3). Unlike the situation described in SCA3/MJD (23), the 
sex of the affected individual does not appear to affect this 
correlation greatly. When disease was categorized by number of 
decades between clinically detectable and debilitating disease, 
correlation was noted (r = 0.62, P<0.0001) by simple regression 
analysis.
Consistent with anticipation previously observed in many of 
the SCA7 kindreds, as age of onset decreased, repeat length
increased in each generation. Kindreds where three generations 
of SCA7 patients were studied had an average age of onset of 
48.3 ± 6.4 for generation I, 31.6 ± 10.7 for II and 15.6 ± 9.0 for 
III. Inverse correlation is seen in the expanded allele data, with a 
mean CAG repeat length of 42.1 ± 4.3 (range 34-47, n = 7) for 
the first generation, 47.1 ± 5.0 (39-57, n = 16) for the second and 
54.7 ± 16.0 (38-103, n = 23) for the third generation. Smaller 
kindreds with a two generation history of SCA7 showed an 
average age of onset of 42.4 ± 10.0 years with a mean repeat 
length of 45.5 ± 5.5 repeats (40-58, n = 11) for generation I and
19.2 ± 5.7 years and 49.6 ± 8.5 repeats (39-66, n = 16) for 
generation II.
Effects of transmitting parent on repeat length 
expansion
Parent-child transmission of the disease allele showed expansion 
of the CAG repeat in 32 of 44 cases. The repeat length differential 
between generations ranged from -13 to +62, with a mean total 
expansion of 7 ± 3.5 (mode = 3) repeats per transmission. A 
significant (P<0.001) difference between paternal and maternal 
transmission of the dynamic mutation exists in our kindreds as has 
been observed in other neurodegenerative trinucleotide repeat 
expansion diseases (24) [reviewed in (19)]. Whereas 33 maternal 
transmissions produced anywhere from -13 to +17 CAG repeats 
in offspring averaging 3.8 ± 3 repeat expansions, 11 paternal 
transmissions ranged from -6 to +62 repeats in offspring, 
averaging 16.6 ± 11 repeats (Fig. 4). Nine of the 10 as well as the 
two largest decreases in repeat length (-13, -8) were due to 
maternal transmission, and the four largest increases (+24, +24, 
+38, +62) were due to paternal transmission. However, the 
average degree of anticipation is similar betweeen the sexes, with 
a mean age of onset differential from paternal transmissions of
20.2 ± 10.5 years and of 20.2 ± 9.5 years from maternal 
transmissions.
In our kindreds, it is notable that whereas repeat length 
expansion is more dramatic in paternal transmissions, the 
majority of actual transmissions of expanded alleles are maternal 
in a 3:1 ratio (33 maternal versus 11 paternal, P<0.001). If 
generational disease histories are taken into account (where 
DNA, and therefore repeat length data was unavailable), the 
female:male ratio of the disease-transmitting parent increases to 
4:1 (65 female versus 16 male disease-transmitting parents). 
Furthermore, this bias in maternal disease transmission was seen 
in all large kindreds and in all of the smaller kindreds except two. 
It should be noted that the total number of females in our study 
was slightly greater than males, but this difference was not 
statistically significant (P>0.05).
Whereas an expanded (>17 repeats) parental allele was 
necessary for transmission of the dynamic mutation, the size of 
this allele could not be correlated significantly to the extent of 
transmission instability. This may be due to the fact that the range 
of expansions observed in 44 parents was confined between 34 
and 54 repeats. Within this sample, no individual or sub-range of 
repeat length could significantly show a differential propensity 
for instability (Fig. 4).
DISCUSSION
The mutation causing SCA7 comprises a transcribed translated 
CAG repeat; this is a common motif among the ‘type I ’ [as
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Figure 1. Repeat length of SCA7 alleles. The x-axis is the number of CAG repeats in all three graphs. The y-axis is total chromosomes in (a) and allele frequency 
in (b) and (c). (a) The filled columns in the first row represent 146 alleles from affected and pre-symptomatic individuals considered to be at risk by genotype. The 
shaded columns in the second row represent 144 alleles from unaffected family members. The distribution of the 210 unexpanded alleles from unaffected unrelated 
individuals is shown in the open columns in the rear. (b) Similar frequency distribution of unexpanded alleles in three populations. Columns are as described above. 
(c) Expanded SCA7 alleles (n = 74) show a wide distribution from 34 to 103 repeats; no single allele represents >9% of the total.
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Figure 2. The autoradiogram of amplified products spanning the CAG repeat 
in SCA7 shows sharp bands and no heterogeneity in unexpanded alleles 
(bottom) but a range of products in expanded alleles (top). The repeat length of 
expanded alleles was determined by the darkest (usually central) band, which 
is flanked by 1-3 larger and smaller PCR products, which are usually lighter. 
Details of the PCR amplification are given in the text.
categorized in (19)] trinucleotide expansion diseases which 
include HD, SCA1, SCA2, SCA3, SCA6 , DRPLA and SBMA. 
Other notable similarities with these diseases are autosomal 
dominant inheritance, generational anticipation, paternal bias and 
a cell-specific neurodegenerative phenotype despite widespread 
gene expression.
We have analyzed the dynamic mutation in 17 SCA7 families 
and correlated repeat length expansion with phenotype and 
inheritance pattern, and typed a large sample of independent 
normal chromosomes for comparative analysis. This study 
represents the largest analysis of SCA7 repeat length in affected 
and unaffected individuals to date. The observed difference 
between normal and expanded alleles is 17 repeats, a relatively 
large differential in the type I group. This striking contrast 
between normal and expanded alleles raises the possibility that 
predictive assays for disease potential in at-risk individuals might 
be relatively straightforward. Nevertheless, despite a correlation
between quantifiable repeat length and age of onset and disease 
course, a genotypic assay based on SCA7 allele size cannot 
provide sufficient predictive value for clinical prognosis.
Although the range of repeat expansions seen in affected 
individuals is similar to that seen in many of the aforementioned 
diseases, it is notable that the normal alleles show low poly­
morphism and are constrained to a narrow range. Furthermore, 
with >97% of the unexpanded alleles harboring between 10 and 
13 CAG repeats, the normal range is centered around a shorter 
CAG repeat length relative to the normal ranges seen in all other 
polyglutamine tract diseases except for SCA6 (25). We (data not 
shown) and others (18) have noted that in normal SCA7 alleles, 
the CAG tract lacks interrupting trinucleotides. As such inter­
vening sequence have the hypothesized role of stabilizing repeat 
length (26), it is paradoxical that unexpanded alleles show such 
low heterogeneity. Despite a lack of interrupting trinucleotide 
within the CAG tract, low repeat length alleles could remain quite 
stable, explaining the limited polymorphism seen in unexpanded 
alleles in our sample. However, expansions beyond the low, 
narrow range seen in normal chromosomes would be expected to 
be highly unstable within populations. Indeed, this marked 
instability is seen in expanded alleles, and appears to be more 
dramatic than in other known polyglutamine tract diseases. As 
instability and subsequent repeat expansion contribute to age of 
onset and severity of disease, selective pressures might be 
expected to exist to keep repeat length below a threshold where 
the allele becomes prone to instability. An initiating gene 
conversion event causing duplication of the repeat sequence (27), 
might precipitate the appearance of the expanded allele; it is 
interesting to note in this regard that the smallest expanded allele 
is exactly twice as large as the largest unexpanded allele (both 
alleles occur in the same individual, who is currently asympto­
matic at the age of 48). Due to the highly unstable nature of the 
repeat, the subsequent morbidity and the autosomal dominant 
nature of the disease, this mutation would not be expected to be 
transmitted intact through many generations before becoming 
incompatible with further transmission; this is consistent with the 
fact that SCA7 has a lower prevalence than most of the type I 
diseases (1,2,14). Unequal sister chromatid exchange, poly­
merase slippage or changes in cis- (28) or trans-acting elements 
[reviewed in (29) and (30)] may also be responsible for initial 
and/or subsequent events conferring instability on the normal 
CAG repeat; more intensive sequence analysis on this large 
patient sample may give insight into these possibilities.
The paternal bias in transmission of expanded alleles is 
particularly noticeable, and extends the pattern seen in other type 
I dynamic mutations. What is appreciated in this large sample of 
SCA7 kindreds is the further observation that actual disease 
transmission shows a strong maternal bias. Although fathers, on 
average, transmit significantly larger alleles to their offspring, 
mothers appear to be more consistent in passing on expanded 
alleles and thus maintaining disease within kindreds. Although 
females comprise 57% of total SCA7 family members and make 
up 64% of individuals harboring expanded alleles, they are 
responsible for a statistically significant 75% of all expanded 
allele transmissions and >80% of disease transmissions deter­
mined by pedigree history. This pattern can also be seen in 
previously described SCA7 families (16,31-36). In a review of 
17 other described kindreds with an autosomal dominant 
degenerative cerebellar/retinal phenotype where a geneology was 
shown, or data regarding sex of affecteds and transmitting parents
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Figure 3. Quadratic regression analysis of repeat length versus age of onset gives a Pearson correlation coefficient of r = -0.80 P<0.0001. Males (squares) show a 
slightly, but not significantly earlier age of onset for a given repeat length.
Figure 4. Parental effects on expanded allele transmission. Paternal transmission (filled squares) is responsible for more dramatic expansion changes seen in offspring, 
although more maternal transmissions (shaded circles) of expanded alleles occur.
could be otherwise delineated, the sex of the disease-transmitting 
parent was predominantly female (84 maternal transmissions 
versus 56 paternal). Although the significance (P<0.05) of this 
statistic in the meta-study is not as strong as that seen in our 
kindreds, the skew is still striking when one considers the fact that 
the actual ratio of affected females to males is almost exactly 50% 
(82 affected females versus 83 males).
Possible explanations for this female disease-transmitting bias 
include a potential selective disadvantage for unstable, greatly 
expanded paternal alleles at the gametic stage (i.e. spermato­
genesis), at fertilization or in utero. This is entirely consistent with 
observations of greater allele instability in sperm populations 
seen in other trinucleotide repeat expansion disease (37-41). If 
this was the case, one would expect fathers with expanded alleles
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to have significantly fewer than 0.50 of total progeny harboring 
expanded alleles. Where genotypes of sibships derived from 
affected fathers are known, this is not seen, but this sample size 
is quite small (6/11 children of affected fathers with expanded 
SCA7 alleles). It is unknown whether increased fetal wastage 
occurs in families where the father is affected. An alternate 
explanation of the observed bias takes both genetic and social 
factors into account: as children of affected fathers would be 
expected to be more severely affected with earlier age of onset, 
this could impact the father's decision to have more children. 
Indeed, although the percentage of affected males with children 
is approximately equivalent to that of affected females with 
children (83% versus 90%), sibships derived from affected 
fathers are smaller than those from affected mothers (mean 
paternal sibship size is 2.4 ± 1.7, mean maternal sibship size is 
4.0 ± 3.1).
Nonetheless, the possibility that in utero pathology resulting 
from the presence of a greatly expanded paternal allele remains 
intriguing as there are hints that the SCA7 protein product, 
ataxin-7, may act as a transcription factor; as such it may play a 
role in development. The polyglutamine and polyproline tracts in 
ataxin-7 resemble those found in certain homeodomain proteins 
and transcription factors (42,43). Expanded ataxin-7 has been 
localized to the nuclear fraction using an antibody to poly­
glutamines (21), and a putative nuclear localization sequence in 
the SCA7 open reading frame suggests that the normal protein 
may also act within the nucleus. Study of other type I proteins 
offer tantalizing, albeit indefinite clues: the androgen receptor (in 
SBMA) is a known transcription factor, and huntingtin also 
carries polyglutamine/polyproline tracts (44) and is implicated as 
necessary for development (45-47). Further examination of 
ataxin-7 directed towards understanding its potential for trans­
criptional regulation as well as interaction with other proteins 




The previously reported SCA7 kindreds constituted 75 family 
members, 38 of who were predicted to carry the SCA7 disease 
allele by genotype; of these 38, 25 were deemed clinically 
affected by exam. Fourteen additional SCA7 kindreds 
incorporating 70 individuals were included in the analysis. Two 
large and nine smaller kindreds were of European origin, one 
large and two smaller kindreds were African-American, one 
large kindred was native Peruvian and a small Liberian and small 
Korean kindred were included in the study. In all, 145 SCA7 
family members were studied: 72 unaffected, 59 affected and 14 
asymptomatic individuals believed to carry the disease allele by 
linkage analysis. To determine relative frequencies of normal 
alleles and heterogeneity of genetic polymorphism, 105 unaf­
fected, unrelated individuals derived from the CEPH reference 
panel were analyzed.
Age of disease onset from patient histories was based on the 
time at which individuals first noted visual disturbances or 
problems with balance; visual changes are usually noted prior to 
difficulty with coordination, and Tritan axis color blindness is a 
reliable indicator of early symptoms (14). Clinical evaluation by
neuro-ophthalmological exam was done to determine affected 
status. For patients where the disease course was known, duration 
from clinically detectable disease to debilitating disease 
(perambulatory incapacity and/or visual ability reduced to 
light/dark perception only) was categorized broadly by number of 
decades between states.
Subjects (or, in the case of minors, the responsible adult) signed 
a ‘Consent for Participation’ form which was approved by the 
Institutional Review Board for Human Research at the University 
of Utah School of Medicine.
DNA isolation and genotyping analysis
Anti-coagulated venous blood samples obtained from the exam­
ined individuals were used for direct DNA preparations and to 
establish lymphoblastoid cell lines by Epstein-Barr virus trans­
formation as previously described (14). Genotyping using poly­
morphic microsatellite markers was as previously described (15).
Amplification of CAG repeats
Primer pairs 7ALT (5'-AAGGAGCGGAAAGAATGTCG-3') 
and 4U716 (5'-CACGACTGTCCCAGCATCACTT-3') were 
used to amplify human DNA. The 5' termini of primer 7ALT were 
labeled with bacteriophage T4 polynucleotide kinase (Promega) 
and [y-32P]dATP (NEN) at 37 ° C for 30 min. Due to the repetitive 
nature of the DNA sequence and high GC content in and around 
the trinucleotide repeat, amplification by ‘standard’ polymerase 
chain reaction (PCR) was inefficient, especially for larger repeat 
lengths (data not shown). In order to amplify these regions more 
accurately, we used a combination of Taq DNA polymerase (for 
processivity) and Pwo DNA polymerase (for proofreading and 
exonuclease activity) (48). Conditions were as follows: genomic 
DNA (50-100 ng) in 25 p,l of total reaction volume 50 mM 
Tris-HCl (pH 9.2) 16 mM  (NH4)2SO4, 1.75 mM  MgCl2, 280 pM  
dATP, dTTP and dCTP, 80 pM  dGTP (Pharmacia), 200 pM  
7-deaza-2'-dGTP (Boehringer Mannheim), 50 pM  each of 
primers 7ALT and 4U716, 5 pM  5'-[32P]7ALT, 1.5 U  of Pwo 
DNA polymerase (Boehringer Mannheim), 3.5 U  of Taq DNA 
polymerase (Boehringer Mannheim). Thermocycling conditions 
were 95 °C for 5 min followed by 30 cycles of 95 °C for 1 min 
denaturion, 56.5 °C for 1 min annealing, 72 °C for 1 min 
extension, followed by a 7 min final extension step at 72 ° C. After 
addition of 10 p,l of formamide loading buffer (98% formamide, 
0.01 M  NaOH, 0.01% each of xylene cyanol and bromophenol 
blue), PCR products were denatured at 95 °C for 10 min and 
placed on ice. Between 3 and 6 p,l of product were loaded and 
separated by denaturing polyacrylamide gel electrophoresis 
(PAGE) on a 7% bis-acrylamide/acrylamide gel (Bio-Rad) 1x 
TBE, with 32% formamide, 6 M  urea. Products were visualized 
either by autoradiography (Fuji X-ray film) or by Phosphor- 
Imager (Molecular Dynamics) analysis.
Sequencing analysis
Selected sequence was derived from PCR products generated as 
described above. Products were cycle sequenced using dideoxy- 
nucleotide terminators with SequeTherm EXCEL polymerase 
(Epicentre Technologies), run on PAGE and visualized by 
autoradiography. Normal alleles from homozygotes (CAG10 and 
CAG11) as well as an expanded allele (CAG44) were sequenced.
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Regression coefficients, ANOVA table, mean and standard 
deviation data were fit using the StatView statistical analysis 
package version 4.5 for Apple Macintosh (Abacus Concepts, Inc.). 
Determination of significance for comparison of percentages was 
performed by x2 analysis, with Yates correction when necessary. 
Non-parametric analysis comparing means was done by the 
Mann-Whitney U  test. The heterozygosity of unaffected individuals 
was determined by the equation HET = 1 - Epg2 (i = 1...n).
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